Measles-containing-vaccine first-dose (MCV1) immunization coverage in Türkiye
Türkiye: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 92.0% in 2025. ▲ Rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Türkiye, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Türkiye recorded 92.0% for measles-containing-vaccine first-dose (mcv1) immunization coverage in 2025.
The figure is down 2.1% on the previous year and down 5.2% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Türkiye peaked at 98.0% in 2006 and was at its lowest, 75.0%, in 2003.
Türkiye ranks 82nd of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Türkiye, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 87.0% | — |
| 2001 | 91.0% | +4.6% |
| 2002 | 83.0% | -8.8% |
| 2003 | 75.0% | -9.6% |
| 2004 | 81.0% | +8.0% |
| 2005 | 91.0% | +12.3% |
| 2006 | 98.0% | +7.7% |
| 2007 | 96.0% | -2.0% |
| 2008 | 97.0% | +1.0% |
| 2009 | 97.0% | +0.0% |
| 2010 | 97.0% | +0.0% |
| 2011 | 98.0% | +1.0% |
| 2012 | 96.0% | -2.0% |
| 2013 | 98.0% | +2.1% |
| 2014 | 94.0% | -4.1% |
| 2015 | 97.0% | +3.2% |
| 2016 | 98.0% | +1.0% |
| 2017 | 96.0% | -2.0% |
| 2018 | 96.0% | +0.0% |
| 2019 | 97.0% | +1.0% |
| 2020 | 95.0% | -2.1% |
| 2021 | 96.0% | +1.1% |
| 2022 | 95.0% | -1.0% |
| 2023 | 95.0% | +0.0% |
| 2024 | 94.0% | -1.1% |
| 2025 | 92.0% | -2.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 89.6% | 75.0% | 98.0% | 10 |
| 2010s | 96.7% | 94.0% | 98.0% | 10 |
| 2020s | 94.5% | 92.0% | 96.0% | 6 |
Countries ranked near Türkiye
More health data for Türkiye
- Un projection of annual infant deaths, annual growth rate -1.72 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5275 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,582 deaths per 1,000 people (2090)
- Number of infants who die before age 1 858 deaths (2100)
- Population ages 0-14, female, annual growth rate -1.61 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1031 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.53 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1072 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Türkiye?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Türkiye was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Türkiye?
- The highest recorded value was 98.0% in 2006.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Türkiye?
- The lowest recorded value was 75.0% in 2003.
- How does Türkiye rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Türkiye ranks 82nd out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Türkiye?
- Over the last ten years it is down 5.2%. The long-run trend across the full record is rising.
- Where does this Türkiye data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).